Epidemiology of meningiomas;Épidémiologie des méningiomes

Neurochirurgie

Volumn 64, Issue 1, 2018, Pages 5-14

  Baldi, I ^a   Engelhardt, J ^a   Bonnet, C ^a   Bauchet, L ^b   Berteaud, E ^a   Gruber A ^a   Loiseau, H ^a  

^a UNIVERSITÉ DE BORDEAUX   (France)

^b GUI DE CHAULIAC HOSPITAL   (France)

Author keywords

Brain tumors; Epidemiology; Incidence; Meningioma; Registry; Risk factor

Indexed keywords

NITROSO DERIVATIVE; PESTICIDE;

ALLERGY; AUTOIMMUNE DISEASE; DIETARY INTAKE; DISEASE BURDEN; DISEASE PREDISPOSITION; ELECTROMAGNETIC RADIATION; ELECTROMAGNETISM; ETHNICITY; GENETIC DISORDER; GENETIC POLYMORPHISM; GEOGRAPHICAL VARIATION (SPECIES); HUMAN; INCIDENCE; IONIZING RADIATION; MENINGIOMA; NONHUMAN; PATHOPHYSIOLOGY; REVIEW; RISK FACTOR; SEX;

HUMANS; INCIDENCE; MENINGEAL NEOPLASMS; MENINGIOMA; RISK FACTORS;

EID: 85024904320     PISSN: 00283770     EISSN: 17730619     Source Type: Journal    
DOI: 10.1016/j.neuchi.2014.05.006     Document Type: Review

References (127)

1. Ostrom, Q.T., Gittleman, H., et al. CBTRUS Statistical Report: primary brain and central nervous system tumors diagnosed in the United States in 2006–2010. Neuro Oncol, 15(Suppl 2), 2013 ii1–56.
2. McCarthy, B.J., Davis, F.G., et al. Factors associated with survival in patients with meningioma. J Neurosurg 88 (1998), 831–839.
3. Claus, E.B., Bondy, M.L., et al. Epidemiology of intracranial meningioma. Neurosurgery 57 (2005), 1088–1095 [discussion –95].
4. Ohgaki, H., Epidemiology of brain tumors. Methods Mol Biol 472 (2009), 323–342.
5. Wrensch, M., Minn, Y., et al. Epidemiology of primary brain tumors: current concepts and review of the literature. Neuro Oncol 4 (2002), 278–299.
6. Barnholtz-Sloan, J.S., Kruchko, C., Meningiomas: causes and risk factors. Neurosurg Focus, 23, 2007, E2.
7. Bondy, M.L., Scheurer, M.E., et al. Brain tumor epidemiology: consensus from the Brain Tumor Epidemiology Consortium. Cancer 113 (2008), 1953–1968.
8. Wiemels, J., Wrensch, M., et al. Epidemiology and etiology of meningioma. J Neurooncol 99 (2010), 307–314.
9. Loiseau, H., Huchet, A., et al. Epidémiologie des tumeurs cérébrales primitives. Rev Neurol (Paris) 165 (2009), 650–670.
10. Gomes, J., Al Zayadi, A., et al. Occupational and environmental risk factors of adult primary brain cancers: a systematic review. Int J Occup Environ Med 2 (2011), 82–111.
11. Davis, F.G., Kupelian, V., et al. Prevalence estimates for primary brain tumors in the United States by behavior and major histology groups. Neuro Oncol 3 (2001), 152–158.
12. Porter, K.R., McCarthy, B.J., et al. Prevalence estimates for primary brain tumors in the United States by age, gender, behavior, and histology. Neuro Oncol 12 (2010), 520–527.
13. Duong, L.M., McCarthy, B.J., et al. Descriptive epidemiology of malignant and nonmalignant primary spinal cord, spinal meninges, and cauda equina tumors, United States, 2004–2007. Cancer 118 (2012), 4220–4227.
14. Klaeboe, L., Lonn, S., et al. Incidence of intracranial meningiomas in Denmark, Finland, Norway and Sweden, 1968–1997. Int J Cancer 117 (2005), 996–1001.
15. Radhakrishnan, K., Mokri, B., et al. The trends in incidence of primary brain tumors in the population of Rochester, Minnesota. Ann Neurol 37 (1995), 67–73.
16. Nakamura, H., Makino, K., et al. Epidemiological study of primary intracranial tumors: a regional survey in Kumamoto prefecture in southern Japan – 20-year study. Int J Clin Oncol 16 (2011), 314–321.
17. Cea-Soriano, L., Wallander, M.A., et al. Epidemiology of meningioma in the United Kingdom. Neuroepidemiology 39 (2012), 27–34.
18. Christensen, H.C., Kosteljanetz, M., et al. Incidences of gliomas and meningiomas in Denmark, 1943 to 1997. Neurosurgery 52 (2003), 1327–1333 [discussion 33–4].
19. Greig, N.H., Ries, L.G., et al. Increasing annual incidence of primary malignant brain tumors in the elderly. J Natl Cancer Inst 82 (1990), 1621–1624.
20. Lehrer, S., Green, S., et al. Association between number of cell phone contracts and brain tumor incidence in nineteen U.S. States. J Neurooncol 101 (2011), 505–507.
21. Counsell, C.E., Collie, D.A., et al. Limitations of using a cancer registry to identify incident primary intracranial tumours. J Neurol Neurosurg Psychiatry 63 (1997), 94–97.
22. Davis, F.G., Bruner, J.M., et al. The rationale for standardized registration and reporting of brain and central nervous system tumors in population-based cancer registries. Neuroepidemiology 16 (1997), 308–316.
23. Gurney, J.G., Kadan-Lottick, N., Brain and other central nervous system tumors: rates, trends, and epidemiology. Curr Opin Oncol 13 (2001), 160–166.
24. Helseth, A., Mork, S.J., Primary intraspinal neoplasms in Norway, 1955 to 1986. A population-based survey of 467 patients. J Neurosurg 71 (1989), 842–845.
25. Davis, F.G., Malinski, N., et al. Primary brain tumor incidence rates in four United States regions, 1985–1989: a pilot study. Neuroepidemiology 15 (1996), 103–112.
26. Surawicz, T.S., McCarthy, B.J., et al. Descriptive epidemiology of primary brain and CNS tumors: results from the Central Brain Tumor Registry of the United States, 1990–1994. Neuro Oncol 1 (1999), 14–25.
27. Jukich, P.J., McCarthy, B.J., et al. Trends in incidence of primary brain tumors in the United States, 1985–1994. Neuro Oncol 3 (2001), 141–151.
28. Hoffman, S., Propp, J.M., et al. Temporal trends in incidence of primary brain tumors in the United States, 1985–1999. Neuro Oncol 8 (2006), 27–37.
29. Brown, M., Schrot, R., et al. Incidence of first primary central nervous system tumors in California, 2001–2005. J Neurooncol 94 (2009), 249–261.
30. Deorah, S., Lynch, C.F., et al. Trends in brain cancer incidence and survival in the United States: surveillance, epidemiology, and end results program, 1973 to 2001. Neurosurg Focus, 20, 2006, E1.
31. Johannesen, T.B., Angell-Andersen, E., et al. Trends in incidence of brain and central nervous system tumors in Norway, 1970–1999. Neuroepidemiology 23 (2004), 101–109.
32. Deltour, I., Johansen, C., et al. Time trends in brain tumor incidence rates in Denmark, Finland, Norway, and Sweden, 1974–2003. J Natl Cancer Inst 101 (2009), 1721–1724.
33. Kaneko, S., Nomura, K., et al. Trend of brain tumor incidence by histological subtypes in Japan: estimation from the Brain Tumor Registry of Japan, 1973–1993. J Neurooncol 60 (2002), 61–69.
34. Kuratsu, J., Ushio, Y., Epidemiological study of primary intracranial tumors: a regional survey in Kumamoto Prefecture in the southern part of Japan. J Neurosurg 84 (1996), 946–950.
35. Nomura, E., Ioka, A., et al. Trends in the incidence of primary intracranial tumors in Osaka, Japan. Jpn J Clin Oncol 41 (2011), 291–294.
36. Arora, R.S., Alston, R.D., et al. Are reported increases in incidence of primary CNS tumours real? An analysis of longitudinal trends in England, 1979–2003. Eur J Cancer 46 (2010), 1607–1616.
37. Baldi, I., Gruber, A., et al. Descriptive epidemiology of CNS tumors in France: results from the Gironde Registry for the period 2000–2007. Neuro Oncol 13 (2011), 1370–1378.
38. Caldarella, A., Crocetti, E., et al. Is the incidence of brain tumors really increasing? A population-based analysis from a cancer registry. J Neurooncol 104 (2011), 589–594.
39. Dobes, M., Khurana, V.G., et al. Increasing incidence of glioblastoma multiforme and meningioma, and decreasing incidence of Schwannoma (2000–2008): findings of a multicenter Australian study. Surg Neurol Int, 2, 2011, 176.
40. Dobec-Meic, B., Pikija, S., et al. Intracranial tumors in adult population of the Varazdin County (Croatia) 1996–2004: a population-based retrospective incidence study. J Neurooncol 78 (2006), 303–310.
41. Liigant, A., Asser, T., et al. Epidemiology of primary central nervous system tumors in Estonia. Neuroepidemiology 19 (2000), 300–311.
42. Hwang, S.L., Kuo, T.H., et al. The change of relative incidences of intracranial tumors after the use of computed tomography in Taiwan. Kaohsiung J Med Sci 16 (2000), 345–350.
43. Staneczek, W., Janisch, W., Epidemiologic data on meningiomas in East Germany 1961–1986: incidence, localization, age and sex distribution. Clin Neuropathol 11 (1992), 135–141.
44. Materljan, E., Materljan, B., et al. Epidemiology of central nervous system tumors in Labin area, Croatia, 1974–2001. Croat Med J 45 (2004), 206–212.
45. Helseth, A., Incidence and survival of intracranial meningioma patients in Norway 1963–1992. Neuroepidemiology 16 (1997), 53–59.
46. Fogelholm, R., Uutela, T., et al. Epidemiology of central nervous system neoplasms. A regional survey in Central Finland. Acta Neurol Scand 69 (1984), 129–136.
47. Legler, J.M., Ries, L.A., et al. Cancer surveillance series [corrected]: brain and other central nervous system cancers: recent trends in incidence and mortality. J Natl Cancer Inst 91 (1999), 1382–1390.
48. Helseth, A., The incidence of primary central nervous system neoplasms before and after computerized tomography availability. J Neurosurg 83 (1995), 999–1003.
49. Counsell, C.E., Collie, D.A., et al. Incidence of intracranial tumours in the Lothian region of Scotland, 1989–90. J Neurol Neurosurg Psychiatry 61 (1996), 143–150.
50. Larjavaara, S., Haapasalo, H., et al. Is the incidence of meningiomas underestimated? A regional survey. Br J Cancer 99 (2008), 182–184.
51. Pobereskin, L.H., The completeness of brain tumour registration in Devon and Cornwall. Eur J Epidemiol 17 (2001), 413–416.
52. Pobereskin, L.H., Chadduck, J.B., Incidence of brain tumours in two English counties: a population based study. J Neurol Neurosurg Psychiatry 69 (2000), 464–471.
53. Lonn, S., Klaeboe, L., et al. Incidence trends of adult primary intracerebral tumors in four Nordic countries. Int J Cancer 108 (2004), 450–455.
54. McCarthy, B.J., Kruchko, C., Consensus conference on cancer registration of brain and central nervous system tumors. Neuro Oncol 7 (2005), 196–201.
55. McCarthy, B.J., Surawicz, T., et al. Consensus Conference on Brain Tumor Definition for registration. November 10, 2000. Neuro Oncol 4 (2002), 134–145.
56. McKinley, B.P., Michalek, A.M., et al. The impact of age and sex on the incidence of glial tumors in New York state from 1976 to 1995. J Neurosurg 93 (2000), 932–939.
57. Inskip, P.D., Tarone, R.E., et al. Sociodemographic indicators and risk of brain tumours. Int J Epidemiol 32 (2003), 225–233.
58. nd., Racial, ethnic and socioeconomic disparities in the treatment of brain tumors. J Neurooncol 93 (2009), 25–39.
59. Louis, D.N., Ohgaki, H., et al. WHO, (eds.) WHO classification of tumours of the central nervous system, 4th ed., 2007, International Agency for Research on Cancer, Lyon.
60. Schoemaker, M.J., Swerdlow, A.J., et al. Cancer incidence in women with Turner syndrome in Great Britain: a national cohort study. Lancet Oncol 9 (2008), 239–246.
61. Lauper, J.M., Krause, A., et al. Spectrum and risk of neoplasia in Werner syndrome: a systematic review. PLoS One, 8, 2013, e59709.
62. Hemminki, K., Li, X., et al. Parental cancer as a risk factor for brain tumors (Sweden). Cancer Causes Control 12 (2001), 195–199.
63. Malmer, B., Henriksson, R., et al. Familial brain tumours-genetics or environment? A nationwide cohort study of cancer risk in spouses and first-degree relatives of brain tumour patients. Int J Cancer 106 (2003), 260–263.
64. Hemminki, K., Tretli, S., et al. Familial risks in nervous-system tumours: a histology-specific analysis from Sweden and Norway. Lancet Oncol 10 (2009), 481–488.
65. Wrensch, M., Lee, M., et al. Familial and personal medical history of cancer and nervous system conditions among adults with glioma and controls. Am J Epidemiol 145 (1997), 581–593.
66. Malmer, B.S., Feychting, M., et al. Genetic variation in p53 and ATM haplotypes and risk of glioma and meningioma. J Neurooncol 82 (2007), 229–237.
67. Hemminki, K., Li, X., Association of brain tumours with other neoplasms in families. Eur J Cancer 40 (2004), 253–259.
68. Claus, E.B., Calvocoressi, L., et al. Family and personal medical history and risk of meningioma. J Neurosurg 115 (2011), 1072–1077.
69. Hill, D.A., Linet, M.S., et al. Meningioma and schwannoma risk in adults in relation to family history of cancer. Neuro Oncol 6 (2004), 274–280.
70. Malmer, B., Tavelin, B., et al. Primary brain tumours as second primary: a novel association between meningioma and colorectal cancer. Int J Cancer 85 (2000), 78–81.
71. Linos, E., Raine, T., et al. Atopy and risk of brain tumors: a meta-analysis. J Natl Cancer Inst 99 (2007), 1544–1550.
72. Wang, M., Chen, C., et al. Inverse association between eczema and meningioma: a meta-analysis. Cancer Causes Control 22 (2011), 1355–1363.
73. Wiemels, J.L., Wrensch, M., et al. Reduced allergy and immunoglobulin E among adults with intracranial meningioma compared to controls. Int J Cancer 129 (2011), 1932–1939.
74. Turner, M.C., Krewski, D., et al. Allergy and brain tumors in the INTERPHONE study: pooled results from Australia, Canada, France, Israel, and New Zealand. Cancer Causes Control 24 (2013), 949–960.
75. Brenner, A.V., Linet, M.S., et al. History of allergies and autoimmune diseases and risk of brain tumors in adults. Int J Cancer 99 (2002), 252–259.
76. Schneider, B., Pulhorn, H., et al. Predisposing conditions and risk factors for development of symptomatic meningioma in adults. Cancer Detect Prev 29 (2005), 440–447.
77. Wiemels, J.L., Bracci, P.M., et al. Assessment of autoantibodies to meningioma in a population-based study. Am J Epidemiol 177 (2013), 75–83.
78. Kiuru, A., Lindholm, C., et al. XRCC1 and XRCC3 variants and risk of glioma and meningioma. J Neurooncol 88 (2008), 135–142.
79. Sadetzki, S., Flint-Richter, P., et al. Genotyping of patients with sporadic and radiation-associated meningiomas. Cancer Epidemiol Biomarkers Prev 14 (2005), 969–976.
80. Bethke, L., Sullivan, K., et al. The common D302H variant of CASP8 is associated with risk of glioma. Cancer Epidemiol Biomarkers Prev 17 (2008), 987–989.
81. Li, R., Wang, R., et al. Association study on MTHFR polymorphisms and meningioma in northern China. Gene 516 (2013), 291–293.
82. Rajaraman, P., Hutchinson, A., et al. DNA repair gene polymorphisms and risk of adult meningioma, glioma, and acoustic neuroma. Neuro Oncol 12 (2010), 37–48.
83. Bethke, L., Murray, A., et al. Comprehensive analysis of DNA repair gene variants and risk of meningioma. J Natl Cancer Inst 100 (2008), 270–276.
84. Rajaraman, P., Brenner, A.V., et al. Risk of meningioma and common variation in genes related to innate immunity. Cancer Epidemiol Biomarkers Prev 19 (2010), 1356–1361.
85. Machulla, H.K., Steinborn, F., et al. Brain glioma and human leukocyte antigens (HLA) – is there an association. J Neurooncol 52 (2001), 253–261.
86. Rajaraman, P., Schwartz, B.S., et al. Delta-aminolevulinic acid dehydratase polymorphism and risk of brain tumors in adults. Environ Health Perspect 113 (2005), 1209–1211.
87. Rajaraman, P., Stewart, P.A., et al. Lead, genetic susceptibility, and risk of adult brain tumors. Cancer Epidemiol Biomarkers Prev 15 (2006), 2514–2520.
88. Rajaraman, P., Hutchinson, A., et al. Oxidative response gene polymorphisms and risk of adult brain tumors. Neuro Oncol 10 (2008), 709–715.
89. Bhatti, P., Stewart, P.A., et al. Lead exposure, polymorphisms in genes related to oxidative stress, and risk of adult brain tumors. Cancer Epidemiol Biomarkers Prev 18 (2009), 1841–1848.
90. Lai, R., Crevier, L., et al. Genetic polymorphisms of glutathione S-transferases and the risk of adult brain tumors: a meta-analysis. Cancer Epidemiol Biomarkers Prev 14 (2005), 1784–1790.
91. De Roos, A.J., Rothman, N., et al. Variation in genes relevant to aromatic hydrocarbon metabolism and the risk of adult brain tumors. Neuro Oncol 8 (2006), 145–155.
92. Flint-Richter, P., Sadetzki, S., Genetic predisposition for the development of radiation-associated meningioma: an epidemiological study. Lancet Oncol 8 (2007), 403–410.
93. Hosking, F.J., Feldman, D., et al. Search for inherited susceptibility to radiation-associated meningioma by genomewide SNP linkage disequilibrium mapping. Br J Cancer 104 (2011), 1049–1054.
94. Joachim, T., Ram, Z., et al. Comparative analysis of the NF2, TP53, PTEN, KRAS, NRAS and HRAS genes in sporadic and radiation-induced human meningiomas. Int J Cancer 94 (2001), 218–221.
95. Lonn, S., Rothman, N., et al. Genetic variation in insulin-like growth factors and brain tumor risk. Neuro Oncol 10 (2008), 553–559.
96. Bethke, L., Sullivan, K., et al. CASP8 D302H and meningioma risk: an analysis of five case-control series. Cancer Lett 273 (2009), 312–315.
97. Dobbins, S.E., Broderick, P., et al. Common variation at 10p12.31 near MLLT10 influences meningioma risk. Nat Genet 43 (2011), 825–827.
98. Cahan, W.G., Woodard, H.Q., et al. Sarcoma arising in irradiated bone; report of 11 cases. Cancer 1 (1948), 3–29.
99. Umansky, F., Shoshan, Y., et al. Radiation-induced meningioma. Neurosurg Focus, 24, 2008, E7.
100. Yonehara, S., Brenner, A.V., et al. Clinical and epidemiologic characteristics of first primary tumors of the central nervous system and related organs among atomic bomb survivors in Hiroshima and Nagasaki, 1958–1995. Cancer 101 (2004), 1644–1654.
101. Preston, D.L., Ron, E., et al. Tumors of the nervous system and pituitary gland associated with atomic bomb radiation exposure. J Natl Cancer Inst 94 (2002), 1555–1563.
102. Modan, B., Baidatz, D., et al. Radiation-induced head and neck tumours. Lancet 1 (1974), 277–279.
103. Ron, E., Modan, B., et al. Tumors of the brain and nervous system after radiotherapy in childhood. N Engl J Med 319 (1988), 1033–1039.
104. Sadetzki, S., Chetrit, A., et al. Long-term follow-up for brain tumor development after childhood exposure to ionizing radiation for tinea capitis. Radiat Res 163 (2005), 424–432.
105. Bowers, D.C., Nathan, P.C., et al. Subsequent neoplasms of the CNS among survivors of childhood cancer: a systematic review. Lancet Oncol 14 (2013), e321–e328.
106. Taylor, A.J., Little, M.P., et al. Population-based risks of CNS tumors in survivors of childhood cancer: the British Childhood Cancer Survivor Study. J Clin Oncol 28 (2010), 5287–5293.
107. Neglia, J.P., Robison, L.L., et al. New primary neoplasms of the central nervous system in survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. J Natl Cancer Inst 98 (2006), 1528–1537.
108. Claus, E.B., Calvocoressi, L., et al. Dental x-rays and risk of meningioma. Cancer 118 (2012), 4530–4537.
109. Tavernier, E., Le, Q.H., et al. Secondary or concomitant neoplasms among adults diagnosed with acute lymphoblastic leukemia and treated according to the LALA-87 and LALA-94 trials. Cancer 110 (2007), 2747–2755.
110. Hammer, G.P., Blettner, M., et al. Epidemiological studies of cancer in aircrew. Radiat Prot Dosimetry 136 (2009), 232–239.
111. Carlberg, M., Soderqvist, F., et al. Meningioma patients diagnosed 2007–2009 and the association with use of mobile and cordless phones: a case-control study. Environ Health, 12, 2013, 60.
112. Swerdlow, A.J., Feychting, M., et al. Mobile phones, brain tumors, and the interphone study: where are we now?. Environ Health Perspect 119 (2011), 1534–1538.
113. IARC monographs on the evaluation of carcinogenic risks to humans. Some N-nitroso compounds. 1978, WHO press, Lyon.
114. Huncharek, M., Kupelnick, B., A meta-analysis of maternal cured meat consumption during pregnancy and the risk of childhood brain tumors. Neuroepidemiology 23 (2004), 78–84.
115. Terry, M.B., Howe, G., et al. An international case-control study of adult diet and brain tumor risk: a histology-specific analysis by food group. Ann Epidemiol 19 (2009), 161–171.
116. Hu, J., Little, J., et al. Risk factors for meningioma in adults: a case-control study in northeast China. Int J Cancer 83 (1999), 299–304.
117. Fan, Z., Ji, T., et al. Smoking and risk of meningioma: a meta-analysis. Cancer Epidemiol 37 (2013), 39–45.
118. Claus, E.B., Walsh, K.M., et al. Cigarette smoking and risk of meningioma: the effect of gender. Cancer Epidemiol Biomarkers Prev 21 (2012), 943–950.
119. Acquavella, J., Olsen, G., et al. Cancer among farmers: a meta-analysis. Ann Epidemiol 8 (1998), 64–74.
120. Khuder, S.A., Mutgi, A.B., et al. Meta-analyses of brain cancer and farming. Am J Ind Med 34 (1998), 252–260.
121. Provost, D., Cantagrel, A., et al. Brain tumours and exposure to pesticides: a case-control study in southwestern France. Occup Environ Med 64 (2007), 509–514.
122. Samanic, C.M., De Roos, A.J., et al. Occupational exposure to pesticides and risk of adult brain tumors. Am J Epidemiol 167 (2008), 976–985.
123. Korhonen, K., Salminen, T., et al. Female predominance in meningiomas can not be explained by differences in progesterone, estrogen, or androgen receptor expression. J Neurooncol 80 (2006), 1–7.
124. Cowppli-Bony, A., Bouvier, G., et al. Brain tumors and hormonal factors: review of the epidemiological literature. Cancer Causes Control 22 (2011), 697–714.
125. Claus, E.B., Calvocoressi, L., et al. Exogenous hormone use, reproductive factors, and risk of intracranial meningioma in females. J Neurosurg 118 (2013), 649–656.
126. Cea-Soriano, L., Blenk, T., et al. Hormonal therapies and meningioma: is there a link?. Cancer Epidemiol 36 (2012), 198–205.
127. Wohrer, A., Waldhor, T., et al. The Austrian Brain Tumour Registry: a cooperative way to establish a population-based brain tumour registry. J Neurooncol 95 (2009), 401–411.